Piacentini Mauro

INSTITUTE

Università degli Studi di Roma Tor Vergata

Email

mauro.piacentini@uniroma2.it

ADDRESS

Dipartimento di Biologia – Via della ricerca scientifica, Roma

PHONE

06 72594234 – Fax 06 72594222

Developed skills and lines of research

Mauro Piacentini earned a degree in Biological Sciences from the University of Rome La Sapienza in 1976. Since 2000, he has been a Full Professor at the University of Rome Tor Vergata. Since 1998, he has also served as the Director of the Cellular Biology Laboratory at the National Institute for Infectious Diseases “Lazzaro Spallanzani” in Rome. His studies focus on understanding the molecular mechanisms underlying cell death and autophagy.
Specifically, his research has addressed:

  • The role of type 2 transglutaminase in cell death (apoptosis) and autophagy under physiological conditions and in the pathogenesis of diseases such as cancer, viral infections, and neurodegenerative diseases.
  • The involvement of type 2 transglutaminase in the regulation of mitochondrial functionality and mitophagy.

He has numerous achievements in the scientific field: he is one of the founders of the journals Cell Death and Differentiation (I.F. 2010 = 8.6) and Cell Death & Disease (I.F. 2010 = 6.0), for which he has served as Receiving Editor and Section Editor since 1994. In 2007, he was Guest Editor for Methods in Enzymology, and since 2008, he has been on the Editorial Board of the journal Journal of Biomedicine and Biotechnology (I.F. 2007 = 2.0). Mauro Piacentini has authored over 240 articles in high-impact international journals.

Projects funded by FFC Ricerca as Principal Investigator or as Research Manager

FFC#8/2022
Targeting the STING/Transglutaminase 2-regulated Interferon response as a novel host-direct approach to fight bacterial infections in cystic fibrosis

FFC#15/2020
Targeting the STING/Transglutaminase 2-regulated Interferon response as a novel host-direct approach to fight bacterial infections in Cystic Fibrosis

FFC#10/2018
Dissecting the mechanism of action of the TG2 inhibitor cysteamine on Cystic Fibrosis

FFC#8/2015
Dissecting the role of TG2 in cystic fibrosis pathogenesis: identification of possible novel therapeutic targets

Publications from FFC Research projects